To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

Universitaetsmedizin Greifswald, Greifswald

Istituto Di Ricovero E Cura A Carattere Scientifico (Irccs) Ospedale San Raffaele, Milan

Rcca Md, Llc, Bethesda

Hospital Universitario 12 de Octubre, Madrid

Treviso Hospital, Treviso

Vanderbilt University, Nashville

Baptist Cancer Center, Memphis

Hospital Universitari I Politecnic La Fe, Valencia

Midamerica Cancer Care, Kansas City

Tulane University, New Orleans

Interne 1 - Hematologie Mit Stammzelltransplantation, Hemostaseologie Und Medizinische Onkologie Ord, Linz

Renovatio Clinical Consultants Llc, Spring

Aou San Giovanni Di Dio E Ruggi, Salerno

New Jersey Hematology Oncology Associates Llc, Brick

Texas Oncology - Baylor Sammons Cancer Center, Dallas

Cliniques Universitaires Ucl Saint-Luc, Brussels

Jessa Ziekenhuis, Hasselt

AZ DELTA, Roeselare

Chu Ucl Namur University Hospital Mont-Godinne, Yvoir

Universitatsklinikum Halle (Saale), Halle

Pratia Hematologia Katowice, Katowice